We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$12.4B
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$13.4B
AUM Growth
-$1.18B
(-8.1%)
Cap. Flow
-$624M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
7.94%
Holding
1,057
New
56
Increased
305
Reduced
416
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Innospec
IOSP
|
+$25.1M |
| 2 |
Haemonetics
HAE
|
+$24.2M |
| 3 |
Calix
CALX
|
+$22.2M |
| 4 |
MaxCyte
MXCT
|
+$21.3M |
| 5 |
FRG
Franchise Group, Inc.
FRG
|
+$21.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kulicke & Soffa
KLIC
|
+$37.4M |
| 2 |
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
|
+$32.3M |
| 3 |
Manhattan Associates
MANH
|
+$28.6M |
| 4 |
KRA
Kraton Corporation
KRA
|
+$28.3M |
| 5 |
GPX
GP Strategies Corp.
GPX
|
+$23.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.4% |
| 2 | Technology | 20.93% |
| 3 | Financials | 15.39% |
| 4 | Consumer Discretionary | 13.63% |
| 5 | Materials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WPRT
351
Westport Fuel Systems
WPRT
$37.4M
| $12.2M | 0.09% |
372,257
-7,217
| -2% | -$291K |
|
|
CHX
352
DELISTED
ChampionX
CHX
| $12.2M | 0.09% |
545,305
+358,467
| +192% | +$8.19M |
|
353
Resources Connection
RGP
$144M
| $12.2M | 0.09% |
772,027
+120,790
| +19% | +$1.82M |
|
354
Hyster-Yale Materials Handling
HY
$599M
| $12.1M | 0.09% |
241,445
+40,012
| +20% | +$2.46M |
|
355
ePlus
PLUS
$2.41B
| $12M | 0.09% |
233,256
-39,544
| -14% | -$1.95M |
|
356
Advanced Energy
AEIS
$10B
| $11.9M | 0.09% |
135,927
-106,831
| -44% | -$9.99M |
|
357
Silvercrest Asset Management
SAMG
$76.3M
| $11.8M | 0.09% |
758,000
| – | – |
|
358
Emergent Biosolutions
EBS
$326M
| $11.8M | 0.09% |
235,831
+941
| +0.4% | +$57K |
|
359
Hubbell
HUBB
$23.2B
| $11.8M | 0.09% |
65,337
-89,318
| -58% | -$17.4M |
|
|
SCS
360
DELISTED
Steelcase
SCS
| $11.8M | 0.09% |
929,978
-43,885
| -5% | -$605K |
|
|
HOUS
361
DELISTED
Anywhere Real Estate
HOUS
| $11.7M | 0.09% |
669,054
-120,582
| -15% | -$2.13M |
|
362
Wolverine World Wide
WWW
$1.57B
| $11.7M | 0.09% |
392,959
-97,237
| -20% | -$3.32M |
|
363
Watsco Inc
WSO
$12.5B
| $11.6M | 0.09% |
43,948
-3,148
| -7% | -$883K |
|
|
OPLN
364
Openlane
OPLN
$4.26B
| $11.6M | 0.09% |
708,500
-328,815
| -32% | -$5.55M |
|
365
Varex Imaging
VREX
$778M
| $11.6M | 0.09% |
409,864
-20,536
| -5% | -$570K |
|
366
Radian Group
RDN
$4.68B
| $11.5M | 0.09% |
507,549
-108,811
| -18% | -$2.47M |
|
|
CHS
367
DELISTED
Chicos FAS, Inc.
CHS
| $11.5M | 0.09% |
2,562,424
+112,697
| +5% | +$643K |
|
368
Dolby
DLB
$5.65B
| $11.5M | 0.09% |
130,452
+28,812
| +28% | +$2.79M |
|
369
Orthofix Medical
OFIX
$370M
| $11.4M | 0.09% |
298,865
-154,259
| -34% | -$6.14M |
|
370
Dorchester Minerals
DMLP
$1.49B
| $11.4M | 0.09% |
593,375
-11,720
| -2% | -$197K |
|
|
371
Manhattan Associates
MANH
$12.2B
| $11.3M | 0.08% |
73,674
-183,517
| -71% | -$28.6M |
|
|
ITI
372
DELISTED
Iteris, Inc.
ITI
| $11.2M | 0.08% |
2,130,165
-779,706
| -27% | -$4.56M |
|
373
Entravision Communication
EVC
$749M
| $11.2M | 0.08% |
1,582,864
+820,678
| +108% | +$5.54M |
|
374
National Bankshares
NKSH
$276M
| $11.2M | 0.08% |
308,940
-17,273
| -5% | -$630K |
|
375
Cavco Industries
CVCO
$4.12B
| $11.2M | 0.08% |
47,379
-7,677
| -14% | -$1.85M |
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Royce & Associates held 1,057 positions worth $13.4B, down 8.1% from $14.6B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Royce & Associates withdrew a net $624M in Q3 2021, closing 75 positions and reducing 416 holdings. Its most notable exit was SmileDirectClub, Inc. Class A Common Stock, an estimated $32.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
Against the trend, Royce & Associates opened a new position in Calix worth $23.8M.
- Royce & Associates's largest Q3 2021 buy was Calix: 480,993 shares worth $23.8M.
- Royce & Associates added most to Innospec in Q3 2021, an estimated $25.1M increase.
- Royce & Associates's biggest Q3 2021 reduction was Kulicke & Soffa, cutting an estimated $37.4M.
- Royce & Associates fully exited SmileDirectClub, Inc. Class A Common Stock in Q3 2021, selling an estimated $32.3M.
- Royce & Associates's ten largest holdings make up 7.9% of its $13.4B portfolio in Q3 2021.
- Royce & Associates opened 56 new positions and closed 75 in Q3 2021.
- Royce & Associates's portfolio value fell 8.1% quarter-over-quarter to $13.4B.
Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.